Cosmos Health Stock Market Value
| COSM Stock | USD 0.49 0.02 3.92% |
| Symbol | Cosmos |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.379 | Return On Assets | Return On Equity |
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cosmos Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cosmos Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cosmos Health.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Cosmos Health on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Cosmos Health or generate 0.0% return on investment in Cosmos Health over 90 days. Cosmos Health is related to or competes with Femasys, Scynexis, Lisata Therapeutics, Nexgel, MetaVia, Passage Bio, and CASI Pharmaceuticals. Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company More
Cosmos Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cosmos Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cosmos Health upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 28.14 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 8.16 |
Cosmos Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cosmos Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cosmos Health's standard deviation. In reality, there are many statistical measures that can use Cosmos Health historical prices to predict the future Cosmos Health's volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.94) | |||
| Total Risk Alpha | (1.49) | |||
| Treynor Ratio | (5.38) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cosmos Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cosmos Health January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.10) | |||
| Market Risk Adjusted Performance | (5.37) | |||
| Mean Deviation | 4.16 | |||
| Coefficient Of Variation | (650.93) | |||
| Standard Deviation | 5.96 | |||
| Variance | 35.57 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (0.94) | |||
| Total Risk Alpha | (1.49) | |||
| Treynor Ratio | (5.38) | |||
| Maximum Drawdown | 28.14 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 8.16 | |||
| Skewness | 0.9108 | |||
| Kurtosis | 3.09 |
Cosmos Health Backtested Returns
Cosmos Health secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. Cosmos Health exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cosmos Health's Mean Deviation of 4.16, standard deviation of 5.96, and Risk Adjusted Performance of (0.10) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cosmos Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cosmos Health is expected to be smaller as well. At this point, Cosmos Health has a negative expected return of -0.81%. Please make sure to confirm Cosmos Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cosmos Health performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.2 |
Insignificant reverse predictability
Cosmos Health has insignificant reverse predictability. Overlapping area represents the amount of predictability between Cosmos Health time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cosmos Health price movement. The serial correlation of -0.2 indicates that over 20.0% of current Cosmos Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Cosmos Health Correlation, Cosmos Health Volatility and Cosmos Health Alpha and Beta module to complement your research on Cosmos Health. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Cosmos Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.